Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 1 - Studien 1 bis 3 von insgesamt 3
- Rekrutierung läuftA Randomized, Double-Blind, Phase 3 Trial of Adagrasib plus Pembrolizumab plusChemotherapy vs. Placebo plus Pembrolizumab plus Chemotherapy in Participants withPreviously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell LungCancer with KRAS G12C Mutation (KRYSTAL-4)Molekulare Marker
- Rekrutierung läuftA Phase 1a/1b Study of the pan-KRAS Inhibitor LY4066434 in Participants with KRAS Mutant Solid Tumors
- Rekrutierung läuftA Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients With Previously Treated KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer